Literature DB >> 19109330

Morphine remains gold standard in breakthrough cancer pain.

Vicente Ruiz-Garcia, Eduardo Lopez-Briz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19109330     DOI： 10.1136/bmj.a3104

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.

Authors:  Frank Elsner; Giovambattista Zeppetella; Josep Porta-Sales; Ignacio Tagarro
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Spinal activation of delta opioid receptors alleviates cancer-related bone pain.

Authors:  V Otis; P Sarret; L Gendron
Journal:  Neuroscience       Date:  2011-03-31       Impact factor: 3.590

Review 3.  Breakthrough pain in elderly patients with cancer: treatment options.

Authors:  Sophie Pautex; Nicole Vogt-Ferrier; Gilbert B Zulian
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

Review 4.  Essential pharmacologic options for acute pain management in the emergency setting.

Authors:  David H Cisewski; Sergey M Motov
Journal:  Turk J Emerg Med       Date:  2018-12-10

5.  Investigation and analysis of oncologists' knowledge of morphine usage in cancer pain treatment.

Authors:  Weiran Liu; Shumin Xie; Lin Yue; Jiahao Liu; Stephanie Mu-Lian Woo; Weilin Liu; Adam R Miller; Jing Zhang; Lijun Huang; Lei Zhang
Journal:  Onco Targets Ther       Date:  2014-05-13       Impact factor: 4.147

6.  Morphine Attenuates fNIRS Signal Associated With Painful Stimuli in the Medial Frontopolar Cortex (medial BA 10).

Authors:  Ke Peng; Meryem A Yücel; Sarah C Steele; Edward A Bittner; Christopher M Aasted; Mark A Hoeft; Arielle Lee; Edward E George; David A Boas; Lino Becerra; David Borsook
Journal:  Front Hum Neurosci       Date:  2018-10-04       Impact factor: 3.473
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.